beta-Lactam Resistance

"beta-Lactam Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.

Descriptor ID	D018440
MeSH Number(s)	G06.099.225.500 G06.225.347.500 G07.690.773.984.269.347.500
Concept/Terms	beta-Lactam Resistance beta-Lactam Resistance beta Lactam Resistance beta-Lactamase Resistant Resistant, beta-Lactamase beta Lactamase Resistant beta-Lactam Resistant beta Lactam Resistant beta-Lactamase Resistance Resistance, beta-Lactamase beta Lactamase Resistance

Below are MeSH descriptors whose meaning is more general than "beta-Lactam Resistance".

Biological Sciences [G]
Microbiological Phenomena [G06]
Bacterial Physiological Phenomena [G06.099]
Drug Resistance, Bacterial [G06.099.225]
beta-Lactam Resistance [G06.099.225.500]
Drug Resistance, Microbial [G06.225]
Drug Resistance, Bacterial [G06.225.347]
beta-Lactam Resistance [G06.225.347.500]
Physiological Phenomena [G07]
Pharmacological and Toxicological Phenomena [G07.690]
Pharmacological Phenomena [G07.690.773]
Drug Resistance [G07.690.773.984]
Drug Resistance, Microbial [G07.690.773.984.269]
Drug Resistance, Bacterial [G07.690.773.984.269.347]
beta-Lactam Resistance [G07.690.773.984.269.347.500]

Below are MeSH descriptors whose meaning is related to "beta-Lactam Resistance".

Below are MeSH descriptors whose meaning is more specific than "beta-Lactam Resistance".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "beta-Lactam Resistance" by people in this website by year, and whether "beta-Lactam Resistance" was a major or minor topic of these publications.

Bar chart showing 11 publications over 8 distinct years, with a maximum of 2 publications in 2002 and 2013 and 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	1	2
2007	0	1	1
2010	0	1	1
2013	1	1	2
2014	1	0	1
2015	1	1	2
2016	0	1	1
2018	1	0	1

Below are the most recent publications written about "beta-Lactam Resistance" by people in Profiles.

Hackel MA, Iaconis JP, Karlowsky JA, Sahm DF. Analysis of Potential ?-Lactam Surrogates To Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae. J Clin Microbiol. 2018 04; 56(4).

View in: PubMed
Bartsch SM, Huang SS, Wong KF, Slayton RB, McKinnell JA, Sahm DF, Kazmierczak K, Mueller LE, Jernigan JA, Lee BY. Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae. J Clin Microbiol. 2016 11; 54(11):2757-2762.

View in: PubMed
Kazmierczak KM, Rabine S, Hackel M, McLaughlin RE, Biedenbach DJ, Bouchillon SK, Sahm DF, Bradford PA. Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-?-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2016 Feb; 60(2):1067-78.

View in: PubMed
Biedenbach DJ, Alm RA, Lahiri SD, Reiszner E, Hoban DJ, Sahm DF, Bouchillon SK, Ambler JE. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program. Antimicrob Agents Chemother. 2016 01; 60(1):343-7.

View in: PubMed
Tsiatsiou O, Iosifidis ?, Katragkou A, Dimou V, Sarafidis K, Karampatakis T, Antachopoulos C, Orfanou A, Tsakris A, Drossou-Agakidou V, Roilides E. Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. Eur J Pediatr. 2015 Jan; 174(1):65-74.

View in: PubMed
Ellis C, Chung C, Tijet N, Patel SN, Desjardins M, Melano RG, Toye B. OXA-48-like carbapenemase-producing Enterobacteriaceae in Ottawa, Canada. Diagn Microbiol Infect Dis. 2013 Jul; 76(3):399-400.

View in: PubMed
Master RN, Deane J, Opiela C, Sahm DF. Recent trends in resistance to cell envelope-active antibacterial agents among key bacterial pathogens. Ann N Y Acad Sci. 2013 Jan; 1277:1-7.

View in: PubMed
Bulik CC, Fauntleroy KA, Jenkins SG, Abuali M, LaBombardi VJ, Nicolau DP, Kuti JL. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. J Clin Microbiol. 2010 Jul; 48(7):2402-6.

View in: PubMed
Khan E, Ejaz M, Zafar A, Jabeen K, Shakoor S, Inayat R, Hasan R. Increased isolation of ESBL producing Klebsiella pneumoniae with emergence of carbapenem resistant isolates in Pakistan: report from a tertiary care hospital. J Pak Med Assoc. 2010 Mar; 60(3):186-90.

View in: PubMed
Sahm DF, Benninger MS, Evangelista AT, Yee YC, Thornsberry C, Brown NP. Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001-2005). Otolaryngol Head Neck Surg. 2007 Mar; 136(3):385-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement